Characterization of 11 human sarcoma cell strains: Evaluation of cytogenetics, tumorigenicity, metastasis, and production of angiogenic factors

Cancer

Volumn 95, Issue 7, 2002, Pages 1569-1576

  Hu, Mei ^a   Nicolson, Garth L ^b   Trent II, Jonathan C ^a   Yu, Dihua ^a   Zhang, Lianglin ^a   Lang, Aiqing ^a   Killary, Ann ^a   Ellis, Lee M ^a   Bucana, Corazon D ^a   Pollock, Raphael E ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b INSTITUTE FOR MOLECULAR MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cell strain; Human; Metastasis; Sarcoma; Tumorigenesis

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CARCINOGENICITY; CELL GROWTH; CELL STRAIN; CYTOGENETICS; DIPLOIDY; FEMALE; HUMAN; HUMAN CELL; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL;

ANIMALS; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; HUMANS; LYMPHOKINES; MICE; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PLOIDIES; SARCOMA; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036785468     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10879     Document Type: Article

References (34)

1. Pisters P, O'Sullivan B, Demetri G. Soft Tissue Sarcoma, In: Bast R, Kufe D, Pollock R, et al., editors. Cancer medicine, 5th ed. Hamilton, Ontario: BC Decker, 2000:1903-1930.
2. Patel S. Chemotherapy of soft-tissue sarcoma. Semin Surg Oncol. 1999;17:47-51.
3. Pollock RE, Lang A, Luo J, El-Naggar AK, Yu D. Soft tissue sarcoma metastasis from clonal expansion of p53 mutated tumor cells. Oncogene. 1996;12:2035-2093.
4. Pollock R, Lang A, Ge T, et al. Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control. Clin Cancer Res. 1998;4:1985-1994.
5. Hu M, Pollock RE, Nakamura T, Nicolson GL. Human peritumoral and lung fibroblasts produce paracrine motility factors for recently established human sarcoma cell strains. Int J Cancer. 1995;62:585-592.
6. Hu M, Pollock RE, Nicolson GL. Purification and characterization of human lung fibroblast motility-stimulating factor for human soft tissue Sarcoma cells: identification as an NH2-terminal fragment of human fibronectin. Cancer Res. 1997;57:3577-3584.
7. Ausubel F, Brent R, Kingston R, et al. Current protocols in molecular biology. New York: John Wiley & Sons, 1991.
8. Yu D, Shi D, Scanlon M, Hung MC. Reexpression of neuencoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of EIA. Cancer Res. 1993;53:5784-5790.
9. el-Naggar AK, Lovell M, Callender DL, Killary AM. Limited nonrandom chromosomal aberrations in a recurrent adenoid cystic carcinoma of the parotid gland. Cancer Genet Cytogener. 1999;109:66-69.
10. el-Naggar AK, Lovell M, Killary AM, Batsakis JG. Genotypic characterization of a primary mucoepidermoid carcinoma of the parotid gland by cytogenetic, fluorescence in situ hybridization, and DNA ploidy analysis. Cancer Genet Cytogenet. 1996;89:38-43.
11. Folkman J. Tumor angiogenesis. In: Bast R, Kufe D, Pollock R, et al., editors. Cancer medicine, 5th ed. Hamilton, Ontario: BC Decker, 2000:132-152.
12. Bonfil RD, Vinyals A, Bustuoabad OD, et al. Stimulation of angiogenesis as an explanation of Matrigel-enhanced tumorigenicity. Int J Cancer. 1994;58:233-239.
13. Curran R, Jones E. Tumor structure & diagnosis. New York: Oxford University Press, 1991.
14. Sonobe H, Manabe Y, Furihata M, et al. Establishment and characterization of a new human synovial sarcoma cell line, HS-SY-II. Lab Invest. 1992;67:498-505.
15. Sonobe H, Manabe Y, Furihata M, et al. [Establishment and characterization of a human cell line, HS-MM, derived from a case of clear cell sarcoma]. Hum Cell. 1990;3:352-356.
16. Sonobe H, Furihata M, Iwata J, et al. Morphological characterization of a new human epithelioid sarcoma cell line, ES020488, in vitro and in vivo. Virchows Arch B Cell Pathol Incl Mol Pathol. 1993;63:219-225.
17. Li WW, Cordon-Cardo C, Chen Q, et al. Establishment, characterization and drug sensitivity of four new human soft tissue sarcoma cell lines. Int J Cancer. 1996;68:514-519.
18. Zhang L, Yu D, Hicklin DJ, Harnay JA, Ellis LM, Pollock RE. Combined anti-fetal liver kinase 1 monoclonal antibody and continuous low-dose doxorubicin inhibits angiogenesis and growth of human soft tissue sarcoma xenografts by induction of endothelial cell apoptosis. Cancer Res. 2002;62:2034-2042.
19. Delattre O, Zucman J, Melot T, et al. The Ewing family of tumors - a subgroup of small-round-cell tumors defined by specific chimeric transcripts. New Engl J Med 1994;331:294-299.
20. Akerman M, Dreinhofer K, Rydholm A, et al. Cytogenetic studies on fine-needle aspiration samples from osteosarcoma and Ewing's sarcoma. Diagn Cytopathol. 1996;15:17-22.
21. Douglass EC, Valentine M, Green AA, Hayes FA, Thomplson EI. t(11;22) and other chromosomal rearrangements in Ewing's sarcoma. J Nat Cancer Inst. 1986;77:1211-1215.
22. Workman ML, Soukup SW, Neely JE, et al. Biologic characteristics of four Ewing's sarcomas. Cancer Genet Cytogenet. 1985;15:215-225.
23. Gorman PA, Malone M, Pritchard J, Sheer D. Cytogenetic analysis of primitive neuroectodermal tumors; absence of the t(11;22) in two of three cases and a review of the literature. Cancer Genet Cytogenet. 1991;51:13-22.
24. Sorenson PH, Liu XF, Delattre O, et al. Reverse transcriptase PCR amplification of EWS/FLI-1 fusion transcripts as a diagnostic test for peripheral primitive neuroectodermanl tumors of childhood. Diagn Mol Pathol. 1993;2:147-157.
25. Panagopoulos I, Mertens F, Isaksson M, et al. Clinical impact of molecular and cytogenetic findings in synovial sarcoma. Genes Chromosomes Cancer. 2001;31:362-372.
26. Cole P, Ladanyi M, Gerald WL, et al. Synovial sarcoma mimicking desmoplastic small round-cell tumor: critical role for molecular diagnosis. Med Pediatr Oncol. 1999;32:97-101.
27. Geurts van Kessel A, de Bruijin D, Hermsen L, et al. Masked t(X;18) (p11;q11) in a biphasic synovial sarcoma revealed by FISH and RT-PCR. Genes Chromosomes Cancer. 1998;23:198-201.
28. Kubota T. Metastatic models of human cancer xenografted in the nude mouse: the importance of orthotopic transplantation. J Cell Biochem. 1994;56:4-8.
29. Grossi FS, Zhao X, Romijn JC, et al. Metastatic potential of human renal cell carcinoma: experimental model using subrenal capsule implantation in athymic nude mice. Urol Res. 1992;20:303-306.
30. Sakakibara T, Xu Y, Bumpers HL, et al. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice. Cancer J Sci Am. 1996;2:291.
31. Vassal G, Terrier-Lacombe MI, Lellouch-Tubiana A, et al. Tumorigenicity of cerebellar primitive neuro-ectodermal tumors in athymic mice correlates with poor prognosis in children. Int J Cancer. 1996;69:146-151.
32. Angevin E, Glukhova L, Pavon C, et al. Human renal cell carcinoma xenografts in SCID mice: tumorigenicity correlates with a poor clinical prognosis. Lab Invest. 1999;79:879-888.
33. Pratesi G, Pezzoni G, Giardini R, et al. Growth characteristics of human colorectal and non-small cell lung tumors xenografted into nude mice: possible correlation with prognosis. Tumori. 1986;72:351-356.
34. George BA, Yanik C, Wells RJ, et al. Growth patterns of human neuroblastoma xenografts and their relationship to treatment outcome. Cancer. 1993;72:3331-3339.